Human PARD3B/ALS2CR19/PAR3B ORF/cDNA clone-Mammalian (Non-Viral Vector) plasmid (NM_001302769.2)

Cat. No.: pGMPC001021
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days

Pre-made Human PARD3B/ALS2CR19/PAR3B Non-Viral expression plasmid (overexpression vector) for mouse PARD3B overexpression in unique cell transient transfection and stable cell line development.


Target products collection

Go to PARD3B/ALS2CR19 products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

Purchase
Shipping fee: Limited-time free
For payment issues, contact us.


Product Description

Catalog ID pGMPC001021
Gene Name PARD3B
Accession Number NM_001302769.2
Gene ID 117583
Species Human
Product Type Mammalian (Non-Viral Vector) plasmid (overexpression)
Insert Length 3618 bp
Gene Alias ALS2CR19,PAR3B,PAR3beta,PAR3L
Fluorescent Reporter Null
Mammalian Cell Selection Puromyocin
Fusion Tag 3xflag (C-Terminal)
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGAAAGTGACCGTGTGCTTCGGCAGGACGGGCATCGTGGTGCCCTGCAAGGAGGGCCAGCTGCGCGTCGGCGAGCTCACCCAGCAGGCGCTGCAGCGGTACCTGAAGACCCGGGAGAAGGGTCCTGGTTACTGGGTGAAGATTCATCACTTAGAATATACAGATGGAGGAATCCTGGATCCAGATGATGTCTTGGCAGATGTTGTTGAAGATAAAGACAAGCTGATTGCTGTGTTTGAAGAACAAGAACCACTCCACAAGATTGAGAGCCCCAGTGGAAACCCTGCAGATCGGCAGAGCCCAGATGCTTTTGAGACAGAAGTGGCCGCCCAACTGGCCGCATTTAAGCCAATTGGTGGGGAGATTGAAGTAACCCCTTCTGCTCTAAAACTAGGCACTCCACTGCTGGTGAGGAGAAGCAGTGACCCAGTGCCAGGCCCACCTGCTGATACCCAGCCAAGCGCTTCACACCCTGGTGGCCAGAGTCTGAAACTGGTTGTTCCAGATTCCACGCAGAACTTGGAAGACAGAGAAGTTTTGAATGGTGTACAGACAGAACTACTAACTTCGCCAAGAACTAAGGACACATTGAGTGATATGACAAGAACAGTGGAGATTTCTGGGGAAGGAGGCCCATTGGGAATACATGTAGTGCCCTTCTTTTCATCTCTGAGTGGAAGGATTCTAGGACTCTTCATCCGAGGCATTGAAGACAACAGCAGGTCCAAGCGGGAGGGACTATTTCACGAAAATGAATGTATTGTAAAAATCAACAATGTGGATCTCGTAGACAAAACCTTTGCTCAGGCTCAAGATGTCTTCCGCCAGGCAATGAAATCTCCAAGTGTGCTCCTCCACGTGCTTCCTCCACAAAACCGTGAACAGTATGAAAAGTCAGTCATTGGCTCTCTTAACATTTTTGGTAATAATGATGGCGTTTTGAAAACCAAAGTGCCGCCTCCTGTCCATGGAAAATCGGGACTAAAGACAGCAAATCTCACAGGAACCGATAGTCCTGAAACAGATGCATCAGCTTCCCTGCAACAAAACAAGAGTCCCCGAGTACCAAGGCTGGGAGGAAAACCATCCTCTCCCTCACTCTCGCCTCTCATGGGATTTGGCAGCAATAAAAATGCAAAGAAAATTAAGATTGACCTAAAGAAAGGCCCTGAAGGACTTGGTTTCACTGTGGTTACCAGAGACTCTTCCATACATGGTCCCGGTCCCATTTTTGTAAAAAACATTTTACCAAAGGGAGCAGCAATAAAAGATGGCCGCCTACAATCAGGGGACAGAATTTTGGAGGTAAATGGGAGAGATGTCACCGGACGAACCCAGGAAGAGCTTGTGGCCATGCTCAGGAGCACCAAGCAGGGGGAGACAGCATCGCTGGTCATTGCCCGCCAAGAAGGACATTTTCTGCCCCGAGAGTTGAAAGGAGAACCTGACTGCTGTGCACTCTCTCTGGAGACAAGCGAGCAGCTCACCTTTGAGATCCCCCTGAATGATTCAGGTTCTGCTGGCCTCGGGGTGAGCTTAAAAGGGAACAAATCCAGAGAAACTGGAACAGACTTGGGGATTTTTATCAAATCCATCATTCATGGAGGCGCTGCTTTTAAGGATGGTCGTCTGCGAATGAATGACCAGCTGATTGCAGTTAATGGGGAATCTCTTTTGGGAAAGTCCAACCACGAAGCTATGGAAACACTTAGGCGGTCAATGTCCATGGAGGGAAACATCCGAGGGATGATCCAGTTGGTGATTCTGAGGAGGCCAGAGAGACCAATGGAGGATCCTGCAGAGTGTGGGGCATTTTCCAAGCCATGCTTTGAGAACTGTCAAAATGCTGTAACCACCTCTAGGCGAAATGATAATAGTATCCTGCATCCACTTGGCACTTGCAGTCCACAAGACAAACAGAAAGGTCTATTGCTGCCCAATGACGGATGGGCCGAGAGTGAAGTTCCACCTTCTCCAACACCACATTCTGCTCTGGGATTGGGCCTCGAAGATTACAGCCACAGCTCTGGGGTGGATTCAGCAGTATATTTTCCAGATCAGCACATCAACTTCAGATCTGTGACACCGGCCAGGCAGCCTGAATCAATTAATTTGAAAGCCTCGAAGAGCATGGACCTTGTGCCAGATGAAAGCAAGGTTCACTCATTGGCTGGACAAAAATCGGAATCTCCAAGCAAAGATTTTGGTCCAACTCTGGGTTTGAAAAAGTCCAGCTCCTTGGAGAGTCTGCAGACTGCAGTGGCCGAGGTCAGGAAGAATGACCTTCCCTTTCACAGGCCCCGGCCGCACATGGTTCGAGGCCGAGGCTGCAATGAGAGCTTTAGAGCAGCCATTGACAAATCCTACGATGGACCTGAAGAAATAGAAGCTGACGGTCTGTCTGATAAGAGCTCTCACTCTGGCCAAGGAGCTCTGAATTGTGAGTCTGCCCCTCAGGGGAATTCGGAGCTAGAGGACATGGAAAATAAAGCCAGGAAAGTCAAAAAAACGAAAGAGAAGGAGAAGAAAAAGGAAAAGGGCAAATTGAAAGTCAAGGAGAAAAAGCGCAAAGAGGAGAATGAAGATCCAGAAAGGAAAATAAAGAAGAAGGGCTTCGGCGCCATGCTGAGATTTGGAAAGAAGAAAGAGGATAAGGGTGGAAAGGCTGAGCAGAAAGGTACTCTGAAACATGGTGGCCTGAGAGAAGAAGAGCTGGAGAAAATGAAAGAAGAGCGTGAAAGGATTGGAGCAAAACATCAGGAGCTAAGGGAAAAGCAGGCAAGAGGTCTTCTTGATTATGCTACTGGTGCAATTGGATCAGTGTATGATATGGATGATGATGAAATGGACCCCAATTATGCCAGAGTGAACCACTTTCGGGAACCATGCACATCAGCAAATGTCTTTAGATCTCCATCTCCCCCTCGAGCTGGACCATTTGGTTACCCTCGGGATGGCCATCCACTGTCTCCAGAAAGAGACCACTTAGAGGGTCTCTATGCCAAGGTCAACAAGCCATACCATCCACTGGTTCCAGCTGACAGTGGCCGTCCTACGGGTGGAAGCACTGACCGTATCCAGAAGTTGCGGAAAGAGTATTATCAGGCTCGGAGGGAAGGTTTCCCTTTATATGAAGACGACGAAGGAAGAGCAAGGCCATCTGAGTATGACCTACTCTGGGTGCCTGGAAGGGGTCCAGATGGGAATGCACACAACCTCCGCTTTGAAGGGATGGAGAGGCAGTACGCATCCTTACCCAGGGGAGGACCCGCAGATCCTGTAGACTATCTGCCAGCAGCACCTCGGGGGCTCTACAAGGAAAGGGAGCTTCCCTATTATCCAGGGGCTCATCCTATGCACCCTCCCAAAGGGAGCTATCCCCGCCCCACAGAGCTCAGGGTGGCAGATCTCCGGTATCCTCAGCACTACCCACCCCCGCCAGCTCCCCAGCACAAAGGACCCTTTCGACAAGACGTTCCGCCTTCCCCTCCCCAGCACCAAAGAATGCCAGCCTATCAGGAAACAGGCAGACCAGGGCCCCGTGGGGGCAGCCCAGACCAGTACCCTTACCGAACCCAGGATTCCCGGCAGAAGAACCCCATGACTGCAGCCGTATAG
ORF Protein Sequence MKVTVCFGRTGIVVPCKEGQLRVGELTQQALQRYLKTREKGPGYWVKIHHLEYTDGGILDPDDVLADVVEDKDKLIAVFEEQEPLHKIESPSGNPADRQSPDAFETEVAAQLAAFKPIGGEIEVTPSALKLGTPLLVRRSSDPVPGPPADTQPSASHPGGQSLKLVVPDSTQNLEDREVLNGVQTELLTSPRTKDTLSDMTRTVEISGEGGPLGIHVVPFFSSLSGRILGLFIRGIEDNSRSKREGLFHENECIVKINNVDLVDKTFAQAQDVFRQAMKSPSVLLHVLPPQNREQYEKSVIGSLNIFGNNDGVLKTKVPPPVHGKSGLKTANLTGTDSPETDASASLQQNKSPRVPRLGGKPSSPSLSPLMGFGSNKNAKKIKIDLKKGPEGLGFTVVTRDSSIHGPGPIFVKNILPKGAAIKDGRLQSGDRILEVNGRDVTGRTQEELVAMLRSTKQGETASLVIARQEGHFLPRELKGEPDCCALSLETSEQLTFEIPLNDSGSAGLGVSLKGNKSRETGTDLGIFIKSIIHGGAAFKDGRLRMNDQLIAVNGESLLGKSNHEAMETLRRSMSMEGNIRGMIQLVILRRPERPMEDPAECGAFSKPCFENCQNAVTTSRRNDNSILHPLGTCSPQDKQKGLLLPNDGWAESEVPPSPTPHSALGLGLEDYSHSSGVDSAVYFPDQHINFRSVTPARQPESINLKASKSMDLVPDESKVHSLAGQKSESPSKDFGPTLGLKKSSSLESLQTAVAEVRKNDLPFHRPRPHMVRGRGCNESFRAAIDKSYDGPEEIEADGLSDKSSHSGQGALNCESAPQGNSELEDMENKARKVKKTKEKEKKKEKGKLKVKEKKRKEENEDPERKIKKKGFGAMLRFGKKKEDKGGKAEQKGTLKHGGLREEELEKMKEERERIGAKHQELREKQARGLLDYATGAIGSVYDMDDDEMDPNYARVNHFREPCTSANVFRSPSPPRAGPFGYPRDGHPLSPERDHLEGLYAKVNKPYHPLVPADSGRPTGGSTDRIQKLRKEYYQARREGFPLYEDDEGRARPSEYDLLWVPGRGPDGNAHNLRFEGMERQYASLPRGGPADPVDYLPAAPRGLYKERELPYYPGAHPMHPPKGSYPRPTELRVADLRYPQHYPPPPAPQHKGPFRQDVPPSPPQHQRMPAYQETGRPGPRGGSPDQYPYRTQDSRQKNPMTAAV

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-IP2642-Ab Anti-PARD3B monoclonal antibody
    Target Antigen GM-Tg-g-IP2642-Ag PARD3B protein
    ORF Viral Vector pGMPC001021 Human PARD3B Mammalian (Non-Viral Vector) plasmid


    Target information

    Target ID GM-IP2642
    Target Name PARD3B
    Gene ID 117583, 72823, 707941, 301455, 101089538, 478879, 535378, 100068099
    Gene Symbol and Synonyms 1810008K04Rik,2010002N16Rik,2810455B10Rik,ALS2CR19,PAR3B,PAR3beta,PAR3L,PARD3B
    Uniprot Accession Q8TEW8
    Uniprot Entry Name PAR3L_HUMAN
    Protein Sub-location Introcelluar Protein
    Category Not Available
    Disease Not Available
    Gene Ensembl ENSG00000116117
    Target Classification Not Available

    Predicted to enable phosphatidylinositol binding activity. Predicted to be involved in several processes, including establishment of cell polarity; establishment of centrosome localization; and establishment or maintenance of epithelial cell apical/basal polarity. Located in cell junction. Part of protein-containing complex. [provided by Alliance of Genome Resources, Apr 2022]



    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.